Inebilizumab Clinical Trials
5 recruitingDrug
Phase 24
Showing 1–5 of 5 trials
Recruiting
Phase 2
A Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Inebilizumab in Children With Generalized Myasthenia Gravis (gMG)
Generalized Myasthenia Gravis
Amgen15 enrolled1 locationNCT06987539
Recruiting
Phase 2
A Phase 2 Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune Diseases
Systemic Lupus ErythematosusActive Refractory Rheumatoid Arthritis
Amgen220 enrolled52 locationsNCT06570798
Recruiting
Phase 2
Study of Inebilizumab in Pediatric Subjects With Neuromyelitis Optica Spectrum Disorder
Neuromyelitis Optica Spectrum Disorder
Amgen15 enrolled19 locationsNCT05549258
Recruiting
Phase 2
The ExTINGUISH Trial of Inebilizumab in NMDAR Encephalitis
EncephalitisAutoimmune Encephalitis
University of Utah116 enrolled39 locationsNCT04372615
Recruiting
Inebilizumab in Acute Neuromyelitis Optica Spectrum Disorders
Neuromyelitis Optica Spectrum Disorder
Xuanwu Hospital, Beijing50 enrolled1 locationNCT05891379